03 Sep 2024 11:41 CEST

Issuer

AKER BIOMARINE ASA

3 September 2024: An Extraordinary General Meeting of Aker BioMarine ASA was
held today as a digital meeting with online participation.

All proposals on the agenda were adopted, cf. Notice of the Extraordinary
General Meeting attached to the stock exchange release dated 12 August 2024.

The complete minutes are attached to this release.


For further information, please contact
Christopher Robin Vinter, VP IR & Corporate Finance
Mobile: +47 911 60 820
Email: Christopher.vinter@akerbiomarine.com


About Aker BioMarine
Aker BioMarine is a leading biotech innovator and Antarctic krill-harvesting
company developing krill-derived products for consumer health and wellness as
well as animal nutrition. The company has a strong position in its industry and
is the world's leading supplier of krill, the natural, powerful and health
promoting source of nutrients from the pristine waters of Antarctica. Aker
BioMarine is listed on Oslo Stock Exchange (AKBM). More information is available
at www.akerbiomarine.com.


626919_AKBM ASA - EGM minutes 3 Sep 2024 (1).pdf

Source

Aker BioMarine ASA

Provider

Oslo Børs Newspoint

Company Name

AKER BIOMARINE ASA

ISIN

NO0010886625

Symbol

AKBM

Market

Oslo Børs